Table 4.

Multivariate analysis of severe anemia during the post–CAR-T period

CharacteristicSevere anemia, early post–CAR-T period
n = 129 (55 events)
Severe anemia, late post–CAR-T period
n = 115 (19 events)
OR95% CIP valueOR95% CIP value
Age, y (cont.) 1.01 0.96-1.06 .76    
Sex, female 2.84 1.25-6.70 .014    
Center, United States 1.81 0.80-4.15 .16 0.39 0.10-1.32 .15 
Previous therapy lines >5, yes 0.83 0.37-1.84 .65    
PD before LD, yes 2.12 0.96-4.83 .067 9.63 2.50-56.3 .003 
Grade ≥3 neutropenia, thrombocytopenia, and/or anemia before LD: yes 4.97 1.52-19.0 .011 4.54 1.02-21.3 .045 
CRS grade ≥2, yes 2.58 1.12-6.09 .027    
BT: intensive CTX, yes 0.86 0.24-2.89 .81 7.23 1.53-40.7 .015 
CharacteristicSevere anemia, early post–CAR-T period
n = 129 (55 events)
Severe anemia, late post–CAR-T period
n = 115 (19 events)
OR95% CIP valueOR95% CIP value
Age, y (cont.) 1.01 0.96-1.06 .76    
Sex, female 2.84 1.25-6.70 .014    
Center, United States 1.81 0.80-4.15 .16 0.39 0.10-1.32 .15 
Previous therapy lines >5, yes 0.83 0.37-1.84 .65    
PD before LD, yes 2.12 0.96-4.83 .067 9.63 2.50-56.3 .003 
Grade ≥3 neutropenia, thrombocytopenia, and/or anemia before LD: yes 4.97 1.52-19.0 .011 4.54 1.02-21.3 .045 
CRS grade ≥2, yes 2.58 1.12-6.09 .027    
BT: intensive CTX, yes 0.86 0.24-2.89 .81 7.23 1.53-40.7 .015 

Significant P values are set in boldface.

or Create an Account

Close Modal
Close Modal